A comparison of oral terbutaline and fenoterol in asthma.
Miller Wc, David L. Rice
Abstract
Miller Wc, David L. Rice
Abstract
The effects of fenoterol and terbutaline, new beta 2 selective bronchodilators each administered orally in five mgm doses, was assessed in 33 asthmatics treated for six weeks. Both agents appeared to be equally potent bronchodilators with equally prolonged duration of action. Adrenergic side effects were half as frequent with fenoterol as compared to terbutaline. With both agents statistically significant drug tolerance developed--the clinical significance of which is unknown.
OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effects of fenoterol and terbutaline, new beta 2 selective bronchodilators each administered orally in five mgm doses, was assessed in 33 asthmatics treated for six weeks. Both agents appeared to be equally potent bronchodilators with equally prolonged duration of action. Adrenergic side effects were half as frequent with fenoterol as compared to terbutaline. With both agents statistically significant drug tolerance developed--the clinical significance of which is unknown.
Key concepts: Fenoterol, Terbutaline, Medicine, Asthma, Bronchodilator, Anesthesia, Pharmacology, Internal medicine